Concepedia

Author

Adam Castaño

Columbia UniversityORCID

Also Known As

A Castano, A. Castano, A. Castaño, ADAM CASTAÑO, Adam Castano, Adam Castaño, Jeffrey Geske

85

Publications

5.5K

Citations

23

H-Index

25

Concepts

All Affiliations

Columbia UniversityColumbia University Irving Medical CenterMedical University of South CarolinaMayo ClinicThe Royal Free Hospital
AC

About

Adam Castaño is an author at Columbia University specializing in medicine, cardiology, and radiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

267

2

Engineering

3

3

185

3

Health Sciences

2

2

76

4

Biomedical Engineering

2

2

174

5

Public Health

1

1

16

Adam Castaño

×

21

Publications

4.6K

Citations

16

H-Index

YearCitations

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini,

Circulation

2016

1.9K

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

Adam Castaño, David L. Narotsky, Nadira Hamid,

European Heart Journal

2017

703

<sup>99m</sup> Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses

Sabahat Bokhari, Adam Castaño, Ted Pozniakoff,

Circulation Cardiovascular Imaging

2013

608

Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging

Adam Castaño, Muhammad Haq, David L. Narotsky,

JAMA Cardiology

2016

412

Diflunisal for ATTR Cardiac Amyloidosis

Adam Castaño, Stephen Helmke, Julissa Alvarez,

Congestive Heart Failure

2012

155

Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis

Hannah Rosenblum, Ahmad Masri, David L. Narotsky,

European Journal of Heart Failure

2020

109

Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis

Adam Castaño, Albert J. DeLuca, Richard L. Weinberg,

Journal of Nuclear Cardiology

2015

106

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Ahsan Huda, Adam Castaño, Anindita Niyogi,

Nature Communications

2021

103

TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis

Hannah Rosenblum, Adam Castaño, Julissa Alvarez,

Circulation Heart Failure

2018

102

Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?

Jonah Rubin, Julissa Alvarez, Sergio Teruya,

Amyloid

2017

89

Page 1